BFTUX | FAFGX | BFTUX / FAFGX | |
Total Expense Ratio | 0.75 | 0.40 | 188% |
Annual Report Gross Expense Ratio | 0.76 | 0.40 | 190% |
Fund Existence | 9 years | 5 years | - |
Gain YTD | 1.974 | 5.154 | 38% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 250 | 2,000,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 707M | 306B | 0% |
Annual Yield % from dividends | 0.00 | 0.57 | - |
Returns for 1 year | 21.83 | 7.54 | 290% |
Returns for 3 years | 106.07 | 55.17 | 192% |
Returns for 5 years | 48.48 | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CSHNX | 11.52 | 0.06 | +0.52% |
NYLI Cushing® MLP Premier Investor Class | |||
RAGHX | 26.47 | -0.19 | -0.71% |
Virtus KAR Health Sciences A | |||
AYBLX | 11.36 | -0.10 | -0.87% |
Victory Pioneer Balanced Y | |||
CWICX | 68.31 | -0.73 | -1.06% |
American Funds Capital World Gr&Inc 529C | |||
GCTSX | 46.18 | -0.60 | -1.28% |
Goldman Sachs US Tax-Managed Eq Svc |